📊 ACOG Key Takeaways
Is Alpha Cognition Inc. (ACOG) a Good Investment?
Alpha Cognition is a pre-commercial stage biotech with unsustainable unit economics: $3.5M revenue against $8.1M operating losses and $11.8M cash burn annually. While the balance sheet is strong with $54.2M cash and zero debt, the company's <5-year cash runway and deeply negative margins (-229% operating margin) indicate a business model not yet proven to generate sustainable returns. Only the 42.2% YoY EPS improvement suggests potential progress, but remains insufficient to offset severe operational losses.
Alpha Cognition's fundamentals show a company with limited scale relative to its cost base, producing deeply negative operating and net margins despite reporting revenue. The balance sheet is currently strong, with substantial cash, no meaningful leverage, and high liquidity, but the business is still consuming cash and has not demonstrated durable operating leverage or high-quality growth.
Alpha Cognition Inc. Key Strengths (ACOG)
- Strong balance sheet with $54.2M cash and zero long-term debt
- Exceptional liquidity position (12.64x current ratio)
- Improving diluted EPS year-over-year (+42.2%), suggesting operational improvements
- Strong liquidity position with $35.40M in cash and a 6.69x current ratio
- Debt-free capital structure reduces financial risk and preserves flexibility
- Cash burn is meaningful but manageable in the near term relative to current cash reserves
ACOG Stock Risks: Alpha Cognition Inc. Investment Risks
- Severe cash burn of $11.8M annually against only $3.5M revenue creates <5 year runway
- Operating margin of -229% indicates business model requires fundamental restructuring before viability
- Pre-commercial stage with no clear path to profitability; 11 Form 4 filings suggest insider uncertainty
- Negative operating and free cash flow indicates company is not yet at inflection point for commercialization
- Extremely weak profitability, including -198.4% operating margin and -186.0% net margin
- Negative operating cash flow and free cash flow indicate the business is not self-funding
- Revenue quality and scalability remain uncertain given losses far exceed current revenue base
Key Metrics to Watch
- Revenue growth rate and path to gross profitability
- Operating cash flow trend and monthly burn rate reduction
- Customer acquisition and pipeline developments from SEC filings
- Quarterly revenue growth versus operating expense growth
- Operating cash burn and remaining cash runway
Alpha Cognition Inc. (ACOG) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 12.64x current ratio provides a solid financial cushion.
ACOG Profit Margin, ROE & Profitability Analysis
ACOG vs Healthcare Sector: How Alpha Cognition Inc. Compares
How Alpha Cognition Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Alpha Cognition Inc. Stock Overvalued? ACOG Valuation Analysis 2026
Based on fundamental analysis, Alpha Cognition Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Alpha Cognition Inc. Balance Sheet: ACOG Debt, Cash & Liquidity
ACOG Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Alpha Cognition Inc.'s revenue has declined by 90% over the 5-year period, indicating business contraction. The most recent EPS of $-2.04 indicates the company is currently unprofitable.
ACOG Revenue Growth, EPS Growth & YoY Performance
ACOG Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $2.9M | -$1.7M | $-0.11 |
| Q3 2025 | $2.8M | -$1.3M | $-0.30 |
| Q2 2025 | $1.7M | -$2.1M | $-0.35 |
| Q1 2025 | $2.9M | -$2.0M | $-0.13 |
| Q3 2024 | $100.0M | -$1.9M | $-0.31 |
| Q2 2024 | $100.0M | -$2.1M | $-0.01 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Alpha Cognition Inc. Dividends, Buybacks & Capital Allocation
ACOG SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Alpha Cognition Inc. (CIK: 0001655923)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ACOG
What is the AI rating for ACOG?
Alpha Cognition Inc. (ACOG) has a Combined AI Grade of C from Claude (D) and ChatGPT (C) with 77% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are ACOG's key strengths?
Claude: Strong balance sheet with $54.2M cash and zero long-term debt. Exceptional liquidity position (12.64x current ratio). ChatGPT: Strong liquidity position with $35.40M in cash and a 6.69x current ratio. Debt-free capital structure reduces financial risk and preserves flexibility.
What are the risks of investing in ACOG?
Claude: Severe cash burn of $11.8M annually against only $3.5M revenue creates <5 year runway. Operating margin of -229% indicates business model requires fundamental restructuring before viability. ChatGPT: Extremely weak profitability, including -198.4% operating margin and -186.0% net margin. Negative operating cash flow and free cash flow indicate the business is not self-funding.
What is ACOG's revenue and growth?
Alpha Cognition Inc. reported revenue of $3.5M.
Does ACOG pay dividends?
Alpha Cognition Inc. does not currently pay dividends.
Where can I find ACOG SEC filings?
Official SEC filings for Alpha Cognition Inc. (CIK: 0001655923) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ACOG's EPS?
Alpha Cognition Inc. has a diluted EPS of $-0.32.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is ACOG's fundamental grade?
Based on our AI fundamental analysis in June 2026, Alpha Cognition Inc. has a C grade with 77% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is ACOG stock overvalued or undervalued?
Valuation metrics for ACOG: ROE of -11.3% (sector avg: 15%), net margin of -183.3% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is ACOG's AI grade for 2026?
Our dual AI analysis gives Alpha Cognition Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ACOG's free cash flow?
Alpha Cognition Inc.'s operating cash flow is $-11.8M, with capital expenditures of $1.3K. FCF margin is -333.9%.
How does ACOG compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -183.3% (avg: 12%), ROE -11.3% (avg: 15%), current ratio 12.64 (avg: 2).